These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28777942)

  • 1. Combining hiPSCs and Human Genetics: Major Applications in Drug Development.
    Zhang J; Li H; Trounson A; Wu JC; Nioi P
    Cell Stem Cell; 2017 Aug; 21(2):161-165. PubMed ID: 28777942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells for disease modelling and drug screening.
    Maury Y; Gauthier M; Peschanski M; Martinat C
    Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex Tissue and Disease Modeling using hiPSCs.
    Passier R; Orlova V; Mummery C
    Cell Stem Cell; 2016 Mar; 18(3):309-21. PubMed ID: 26942851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications.
    Elbadry MI; Espinoza JL; Nakao S
    Exp Hematol; 2017 May; 49():9-18. PubMed ID: 28062362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives regarding the potential use of human induced pluripotent stem cells for the development of and research on medicinal products].
    Hayakawa T; Mizuguchi H
    Brain Nerve; 2012 Jan; 64(1):47-57. PubMed ID: 22223501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex disease.
    Grieshammer U; Shepard KA
    Stem Cells Transl Med; 2014 Nov; 3(11):1253-8. PubMed ID: 25359995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing human genetics and stem cells for precision cardiovascular medicine.
    Caudal A; Snyder MP; Wu JC
    Cell Genom; 2024 Feb; 4(2):100445. PubMed ID: 38359791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational prospects for human induced pluripotent stem cells.
    Csete M
    Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How induced pluripotent stem cells are informing drug discovery in psychiatry.
    Sun Y; Dolmetsch RE
    Swiss Med Wkly; 2016; 146():w14241. PubMed ID: 26752334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human iPSC-derived miniature organs: a tool for drug studies.
    Takebe T; Taniguchi H
    Clin Pharmacol Ther; 2014 Sep; 96(3):310-3. PubMed ID: 24848506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells: disease models that show and tell.
    Marx V
    Nat Methods; 2015 Jan; 12(2):111-4. PubMed ID: 25633502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.